Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 04:00PM ET
63.48
Dollar change
+0.26
Percentage change
0.41
%
Index- P/E- EPS (ttm)-1.14 Insider Own1.04% Shs Outstand181.36M Perf Week-12.98%
Market Cap11.52B Forward P/E529.53 EPS next Y0.12 Insider Trans-5.34% Shs Float179.65M Perf Month2.55%
Income-204.15M PEG- EPS next Q-0.48 Inst Own90.03% Short Float3.53% Perf Quarter-2.64%
Sales2.50B P/S4.61 EPS this Y19.60% Inst Trans-1.74% Short Ratio2.64 Perf Half Y-7.40%
Book/sh17.34 P/B3.66 EPS next Y113.19% ROA-3.00% Short Interest6.34M Perf Year-2.94%
Cash/sh4.28 P/C14.82 EPS next 5Y- ROE-6.60% 52W Range56.05 - 100.77 Perf YTD-14.19%
Dividend Est.- P/FCF360.90 EPS past 5Y4.59% ROI-3.63% 52W High-37.01% Beta1.24
Dividend TTM- Quick Ratio2.07 Sales past 5Y43.88% Gross Margin70.14% 52W Low13.26% ATR (14)3.31
Dividend Ex-Date- Current Ratio2.32 EPS Y/Y TTM67.92% Oper. Margin-12.20% RSI (14)42.53 Volatility5.66% 4.78%
Employees6600 Debt/Eq0.82 Sales Y/Y TTM19.93% Profit Margin-8.17% Recom1.32 Target Price89.78
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q61.80% Payout- Rel Volume0.66 Prev Close63.22
Sales Surprise1.26% EPS Surprise36.16% Sales Q/Q16.98% EarningsMay 08 AMC Avg Volume2.40M Price63.48
SMA20-6.99% SMA500.33% SMA200-10.88% Trades Volume1,597,901 Change0.41%
Date Action Analyst Rating Change Price Target Change
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Dec-13-23Initiated Wolfe Research Outperform $95
Oct-10-23Upgrade Piper Sandler Neutral → Overweight $90
Sep-28-23Initiated Bernstein Outperform $83
Aug-02-23Downgrade The Benchmark Company Buy → Hold
May-10-23Upgrade Craig Hallum Hold → Buy $55 → $85
May-05-23Initiated UBS Neutral $73
Mar-09-23Upgrade Citigroup Neutral → Buy $70 → $90
Feb-10-23Downgrade Credit Suisse Outperform → Neutral $50 → $70
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM Loading…
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
06:00AM
Apr-05-24 10:16AM
10:15AM Loading…
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
Mar-22-24 11:30AM
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
Mar-13-24 05:03PM
Mar-11-24 12:59AM
09:55AM Loading…
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
Nov-06-23 09:35AM
Nov-03-23 08:09PM
Nov-02-23 07:23PM
04:02PM
11:03AM
09:40AM
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
11:25AM
Oct-30-23 10:20PM
Oct-27-23 08:11PM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baranick BrianEVP, GM., Precision OncologyApr 02 '24Sale79.4392473,39313,171Apr 03 07:30 PM
Condella SarahEVP, Human ResourcesApr 01 '24Sale70.002,000140,00071,787Apr 03 07:30 PM
Condella SarahEVP, Human ResourcesMar 28 '24Sale70.002,000140,00073,787Apr 01 04:30 PM
Conroy Kevin TPresident and CEOMar 01 '24Sale59.328,271490,6361,299,496Mar 04 08:38 PM
LEVANGIE DANIEL JDirectorMar 01 '24Sale57.505,000287,50022,975Mar 04 08:42 PM
Cunningham EverettChief Commercial OfficerMar 01 '24Sale59.322,412143,08046,179Mar 04 08:38 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01 '24Sale59.322,412143,08010,933Mar 04 08:40 PM
Baranick BrianGen. Mgr., Precision OncologyMar 01 '24Sale59.322,323137,80014,095Mar 04 08:36 PM
ORVILLE JACOB AGeneral Manager, ScreeningMar 01 '24Sale59.322,154127,77514,324Mar 04 08:42 PM
Doyle James EdwardDirectorMar 01 '24Sale57.502,000115,00050,110Mar 04 08:39 PM
Condella SarahEVP, Human ResourcesMar 01 '24Sale59.321,724102,26875,787Mar 04 08:37 PM
Herriott JamesGeneral CounselMar 01 '24Sale59.3286251,1349,125Mar 04 08:41 PM
Herriott JamesGeneral CounselFeb 29 '24Option Exercise0.001,89009,987Mar 04 08:41 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 29 '24Option Exercise0.005,291013,345Mar 04 08:40 PM
Cunningham EverettChief Commercial OfficerFeb 29 '24Option Exercise0.005,291048,591Mar 04 08:38 PM
Conroy Kevin TPresident and CEOFeb 29 '24Option Exercise0.0018,14301,307,767Mar 04 08:38 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 29 '24Option Exercise0.004,724016,418Mar 04 08:36 PM
Condella SarahEVP, Human ResourcesFeb 29 '24Option Exercise0.003,779077,511Mar 04 08:37 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 29 '24Option Exercise0.004,724016,478Mar 04 08:42 PM
Conroy Kevin TPresident and CEOFeb 27 '24Sale56.896,263356,3021,289,624Feb 28 07:35 PM
Cunningham EverettChief Commercial OfficerFeb 27 '24Sale56.893,648207,53543,300Feb 28 07:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27 '24Sale56.892,710154,1728,054Feb 28 07:36 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 27 '24Sale56.892,027115,31611,694Feb 28 07:34 PM
Condella SarahEVP, Human ResourcesFeb 27 '24Sale56.891,880106,95373,732Feb 28 07:35 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 27 '24Sale56.891,879106,89611,754Feb 28 07:38 PM
Herriott JamesGeneral CounselFeb 27 '24Sale56.8978444,6028,097Feb 28 07:38 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 26 '24Option Exercise0.003,954013,633Feb 28 07:38 PM
Cunningham EverettChief Commercial OfficerFeb 26 '24Option Exercise0.007,678046,948Feb 28 07:37 PM
Herriott JamesGeneral CounselFeb 26 '24Option Exercise0.001,64808,881Feb 28 07:38 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26 '24Option Exercise0.005,701010,764Feb 28 07:36 PM
Condella SarahEVP, Human ResourcesFeb 26 '24Option Exercise0.003,954075,612Feb 28 07:35 PM
Conroy Kevin TPresident and CEOFeb 26 '24Option Exercise0.0013,18101,295,887Feb 28 07:35 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 26 '24Option Exercise0.003,954013,721Feb 28 07:34 PM
Conroy Kevin TPresident and CEOFeb 23 '24Option Exercise13.96102,8371,435,6051,344,266Feb 26 05:00 PM
Condella SarahEVP, Human ResourcesFeb 23 '24Sale59.721,02160,97471,658Feb 26 05:00 PM
Conroy Kevin TPresident and CEOFeb 22 '24Sale59.7811,565691,3561,241,429Feb 23 07:59 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22 '24Sale59.781,35180,7635,063Feb 23 08:01 PM
Cunningham EverettChief Commercial OfficerFeb 22 '24Sale59.781,35080,70339,270Feb 23 08:00 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 22 '24Sale59.781,09365,3409,767Feb 23 07:57 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 22 '24Sale59.781,01360,5579,679Feb 23 08:03 PM
Condella SarahEVP, Human ResourcesFeb 22 '24Sale59.781,01360,55772,679Feb 23 07:57 PM
COWARD D SCOTTDirectorFeb 22 '24Sale59.7866339,63444,493Feb 23 07:59 PM
Herriott JamesGeneral CounselFeb 22 '24Sale59.7829117,3967,233Feb 23 08:02 PM
Conroy Kevin TPresident and CEOFeb 21 '24Sale61.504,975305,9621,229,756Feb 22 07:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 21 '24Sale61.501,49391,8203,703Feb 22 07:38 PM
Condella SarahEVP, Human ResourcesFeb 21 '24Sale61.501,07966,35871,658Feb 22 07:36 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 21 '24Sale61.501,07866,2978,658Feb 22 07:40 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 21 '24Sale61.5089555,0428,826Feb 22 07:36 PM
COWARD D SCOTTDirectorFeb 21 '24Sale61.5070643,41943,122Feb 22 07:38 PM
Herriott JamesGeneral CounselFeb 21 '24Sale61.5041525,5226,943Feb 22 07:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 20 '24Option Exercise0.003,11205,196Feb 22 07:38 PM
Conroy Kevin TPresident and CEOFeb 20 '24Option Exercise0.0010,37401,234,731Feb 22 07:37 PM
COWARD D SCOTTDirectorFeb 20 '24Option Exercise0.002,248043,828Feb 22 07:38 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 20 '24Option Exercise0.001,72909,721Feb 22 07:36 PM
Condella SarahEVP, Human ResourcesFeb 20 '24Option Exercise0.002,248072,737Feb 22 07:36 PM
Herriott JamesGeneral CounselFeb 20 '24Option Exercise0.0086407,358Feb 22 07:39 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 20 '24Option Exercise0.002,24809,736Feb 22 07:40 PM
Conroy Kevin TPresident and CEOFeb 15 '24Sale61.4314,791908,6111,224,357Feb 16 06:22 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15 '24Sale61.431,888115,9802,084Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 15 '24Sale61.431,37684,52841,580Feb 16 06:23 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 15 '24Sale61.4396659,3417,488Feb 16 06:26 PM
Condella SarahEVP, Human ResourcesFeb 15 '24Sale61.4396559,28070,489Feb 16 06:21 PM
Herriott JamesGeneral CounselFeb 15 '24Sale61.4342125,8626,494Feb 16 06:25 PM
Conroy Kevin TPresident and CEOFeb 14 '24Option Exercise0.0031,13301,239,148Feb 16 06:22 PM
Condella SarahEVP, Human ResourcesFeb 14 '24Option Exercise0.002,031071,454Feb 16 06:21 PM
Herriott JamesGeneral CounselFeb 14 '24Option Exercise0.0088306,915Feb 16 06:25 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 14 '24Option Exercise0.002,03108,454Feb 16 06:26 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14 '24Option Exercise0.003,97203,972Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 14 '24Option Exercise0.003,972042,956Feb 16 06:23 PM
Condella SarahEVP, Human ResourcesJan 02 '24Sale73.502,000147,00069,423Jan 04 05:19 PM
Baranick BrianGen. Mgr., Precision OncologyJan 02 '24Sale73.5087964,6067,992Jan 04 05:17 PM
Condella SarahEVP, Human ResourcesDec 14 '23Sale70.002,000140,00071,423Dec 18 07:49 PM
Cunningham EverettChief Commercial OfficerOct 12 '23Sale66.4913,007864,83537,909Oct 13 07:59 PM
Cunningham EverettChief Commercial OfficerOct 11 '23Option Exercise0.0027,504050,916Oct 13 07:59 PM
Condella SarahEVP, Human ResourcesSep 01 '23Sale84.364,500379,62075,814Sep 06 04:04 PM
Elliott Jeffrey ThomasChief Financial OfficerAug 21 '23Sale82.9230,2102,505,0130Aug 23 04:08 PM
Baranick BrianGen. Mgr., Precision OncologyAug 07 '23Sale85.041,350114,8048,871Aug 08 04:09 PM
Baranick BrianGen. Mgr., Precision OncologyAug 04 '23Option Exercise0.002,712010,221Aug 08 04:09 PM
Doyle James EdwardDirectorJul 27 '23Sale97.422,000194,84052,110Jul 28 04:06 PM
Herriott JamesGeneral CounselJul 19 '23Sale100.001,300130,0005,964Jul 21 04:04 PM
Zanotti Katherine SDirectorJun 09 '23Sale90.513,027273,97464,629Jun 12 04:17 PM
Doyle James EdwardDirectorJun 09 '23Sale90.511,402126,89554,110Jun 12 04:29 PM
Herriott JamesGeneral CounselJun 08 '23Sale90.001,300117,0007,264Jun 12 04:14 PM
Doyle James EdwardDirectorMay 26 '23Sale80.622,000161,24051,913May 31 04:13 PM
Condella SarahEVP, Human ResourcesMay 10 '23Sale80.006,087486,96080,314May 12 04:11 PM
ORVILLE JACOB AGeneral Manager, ScreeningMay 10 '23Sale80.005,000400,0006,423May 12 04:09 PM
Herriott JamesGeneral CounselMay 10 '23Sale79.851,300103,8058,564May 12 04:07 PM
Condella SarahEVP, Human ResourcesMay 01 '23Sale63.781,00063,78086,401May 03 04:04 PM
Last Close
Apr 18 04:00PM ET
19.98
Dollar change
-0.17
Percentage change
-0.84
%
PHG Koninklijke Philips N.V. ADR daily Stock Chart
Index- P/E- EPS (ttm)-0.54 Insider Own0.00% Shs Outstand906.40M Perf Week-3.01%
Market Cap18.11B Forward P/E11.39 EPS next Y1.75 Insider Trans- Shs Float906.39M Perf Month-3.94%
Income-503.42M PEG- EPS next Q0.30 Inst Own7.59% Short Float0.22% Perf Quarter-14.54%
Sales19.64B P/S0.92 EPS this Y11.56% Inst Trans-26.09% Short Ratio1.91 Perf Half Y5.05%
Book/sh14.66 P/B1.36 EPS next Y17.24% ROA-1.50% Short Interest1.96M Perf Year14.62%
Cash/sh2.28 P/C8.77 EPS next 5Y15.56% ROE-3.59% 52W Range17.40 - 24.27 Perf YTD-14.36%
Dividend Est.0.89 (4.44%) P/FCF9.34 EPS past 5Y- ROI-2.39% 52W High-17.68% Beta0.86
Dividend TTM- Quick Ratio0.78 Sales past 5Y-1.50% Gross Margin40.99% 52W Low14.84% ATR (14)0.36
Dividend Ex-DateMay 12, 2022 Current Ratio1.20 EPS Y/Y TTM69.49% Oper. Margin4.44% RSI (14)43.56 Volatility1.58% 1.40%
Employees69656 Debt/Eq0.64 Sales Y/Y TTM5.03% Profit Margin-2.56% Recom3.38 Target Price22.02
Option/ShortYes / Yes LT Debt/Eq0.58 EPS Q/Q- Payout- Rel Volume0.49 Prev Close20.15
Sales Surprise- EPS Surprise- Sales Q/Q5.04% EarningsApr 29 BMO Avg Volume1.03M Price19.98
SMA20-1.31% SMA50-2.16% SMA200-4.89% Trades Volume504,998 Change-0.84%
Date Action Analyst Rating Change Price Target Change
Feb-07-24Downgrade Exane BNP Paribas Outperform → Underperform
Jul-12-23Initiated Goldman Buy
Jan-17-23Downgrade UBS Neutral → Sell
Oct-18-22Initiated Morgan Stanley Equal-Weight
Oct-14-22Downgrade Deutsche Bank Hold → Sell
Sep-12-22Upgrade Societe Generale Hold → Buy
Sep-06-22Upgrade UBS Sell → Neutral
Jul-25-22Downgrade Societe Generale Buy → Hold
Jun-16-22Downgrade UBS Neutral → Sell
Jan-20-22Downgrade Jefferies Buy → Hold
Apr-17-24 07:17AM
Apr-16-24 09:38AM
Apr-10-24 10:51AM
04:57AM
03:00AM
02:05AM Loading…
02:05AM
Apr-09-24 05:03PM
04:57PM
04:31PM
04:19PM
02:29PM
Apr-08-24 10:29AM
Apr-05-24 12:37PM
Apr-04-24 09:00AM
Apr-02-24 09:16AM
04:00AM Loading…
Mar-22-24 04:00AM
Mar-19-24 05:00AM
Mar-14-24 11:59AM
Mar-13-24 10:18AM
Mar-12-24 11:01AM
09:00AM
08:00AM
Mar-11-24 09:56AM
Mar-06-24 04:00AM
Mar-04-24 08:27AM
Mar-01-24 12:00PM
11:05AM
Feb-29-24 04:00AM
12:04AM
Feb-28-24 09:47AM
04:00AM Loading…
04:00AM
01:00AM
Feb-27-24 06:00AM
Feb-26-24 09:22AM
Feb-23-24 08:03PM
05:09PM
05:03PM
Feb-20-24 03:00AM
02:30AM
02:30AM
Feb-16-24 10:00AM
Feb-15-24 01:33PM
01:14PM
Feb-06-24 09:44AM
09:00AM
05:49AM
05:49AM
Feb-02-24 10:02AM
Feb-01-24 02:23AM
Jan-31-24 02:29PM
01:51PM
09:00AM
Jan-30-24 12:11PM
08:58AM
03:45AM
Jan-29-24 02:05PM
02:04PM
01:42PM
12:46PM
11:55AM
10:55AM
10:50AM
06:40AM
06:01AM
05:18AM
05:06AM
01:18AM
01:01AM
01:00AM
Jan-26-24 06:31AM
Jan-25-24 09:38AM
09:01AM
09:00AM
Jan-19-24 09:45AM
Jan-18-24 04:24AM
Dec-22-23 05:53AM
Dec-21-23 11:50PM
11:28AM
05:12AM
Dec-20-23 03:44PM
02:56PM
Dec-19-23 09:30AM
Dec-18-23 09:50AM
Dec-14-23 08:17PM
09:00AM
05:27AM
Dec-12-23 09:00AM
Dec-04-23 01:08PM
Dec-01-23 08:25AM
Nov-30-23 11:32AM
Nov-29-23 09:00PM
10:41AM
09:00AM
05:19AM
03:01AM
Nov-28-23 01:12PM
09:00AM
08:38AM
Nov-27-23 10:27AM
09:00AM
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Last Close
Apr 18 04:00PM ET
50.18
Dollar change
-0.03
Percentage change
-0.06
%
FEZ SPDR EURO Stoxx 50 ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Broad / Regional Asset TypeEquities (Stocks) TagsEurope Return% 1Y12.45% Shs Outstand Perf Week-2.28%
SponsorState Street (SPDR) ETF Type Tagsequity Return% 3Y5.77% Total Holdings53 Perf Month-3.28%
Fund Family Bond Type Tagslarge-cap Return% 5Y8.77% AUM3.45B Perf Quarter8.03%
IndexEURO STOXX 50 Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y19.59%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year8.43%
Active/Passive Quant Type Tags- Flows% 1M7.89% 52W Range40.23 - 53.02 Perf YTD4.96%
Dividend TTM1.28 (2.55%) ESG Type Tags- Flows% 3M24.55% 52W High-5.35% Beta1.10
Dividend Ex-DateMar 18, 2024 Dividend Type Sector/Theme Flows% YTD24.55% 52W Low24.73% ATR (14)0.63
Expense0.29% Structure Type Region Flows% 1Y RSI (14)36.61 Volatility1.32% 0.98%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.09 Prev Close50.21
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume1.22M Price50.18
SMA20-3.13% SMA50-1.54% SMA2008.19% Trades Volume1,323,045 Change-0.06%
Apr-25-23 07:00AM
Feb-08-23 06:30PM
Mar-19-20 12:12PM
Feb-28-20 12:26PM
Jan-21-20 08:33AM
12:00PM Loading…
Dec-13-19 12:00PM
Sep-23-19 12:05PM
May-22-19 01:42PM
Feb-10-19 05:05PM
Feb-07-19 06:01PM
Sep-07-18 07:39AM
Aug-14-18 12:56PM
Jun-14-18 12:10PM
May-24-18 01:05PM
10:05AM
04:21PM Loading…
May-04-18 04:21PM
Apr-06-18 04:15PM
Feb-26-18 04:15PM
Feb-22-18 06:27PM
Feb-16-18 01:29PM
12:40PM
Jan-22-18 02:20PM
Jan-16-18 04:00PM
Jan-11-18 02:50PM
11:45AM
Jan-10-18 01:50PM
Jan-05-18 09:06AM
Jan-04-18 01:59PM
Dec-26-17 01:45PM
Dec-20-17 10:32AM
02:44PM Loading…
Dec-15-17 02:44PM
Dec-11-17 09:04AM
Dec-05-17 10:32AM
Nov-21-17 10:33AM
Nov-15-17 10:31AM
Nov-07-17 07:33AM
Nov-06-17 11:42AM
Nov-01-17 10:15AM
Oct-30-17 12:40PM
Oct-23-17 11:36AM
Oct-16-17 05:28PM
Oct-13-17 04:10PM
Oct-11-17 10:39AM
Oct-10-17 07:43AM
Oct-09-17 10:38AM
Oct-02-17 05:05PM
04:37PM
11:48AM
Sep-25-17 05:36PM
09:18AM
Sep-21-17 10:06AM
Sep-18-17 09:37AM
Sep-14-17 08:08AM
Sep-11-17 04:06PM
Sep-05-17 03:06PM
01:30PM
Aug-28-17 01:15PM
Aug-25-17 01:06PM
Aug-22-17 07:37AM
Aug-17-17 09:06AM
Aug-16-17 02:05PM
Aug-15-17 11:06AM
Aug-14-17 07:38AM
Aug-10-17 09:06AM
Aug-09-17 01:05PM
Aug-08-17 01:06PM
Aug-01-17 05:59PM
Jul-27-17 03:14PM
03:13PM
11:41AM
Jul-25-17 10:41AM
Jul-21-17 04:00PM
Jul-13-17 01:53PM
Jul-10-17 05:05PM
Jul-06-17 04:29PM
Jul-03-17 12:01PM
Jun-29-17 02:59PM
Jun-27-17 07:43AM
Jun-26-17 10:37AM
Jun-20-17 08:23AM
07:37AM
Jun-14-17 02:33PM
10:38AM
Jun-13-17 03:31PM
07:37AM
Jun-09-17 04:08PM
Jun-07-17 05:35PM
Jun-06-17 12:00PM
Jun-05-17 06:06PM
May-31-17 09:40AM
09:30AM
May-30-17 02:53PM
May-26-17 10:38AM
May-25-17 09:04AM
May-23-17 07:36AM
May-22-17 10:36AM
May-11-17 12:23PM
May-10-17 12:31PM
May-09-17 06:09PM
SPDR EURO STOXX 50 ETF seeks investment results that, before fees and expenses, correspond generally to the total return performance of the EURO STOXX 50 Index. The fund employs a sampling strategy, which means that the fund is not required to purchase all of the securities represented in the index. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is a market capitalization weighted index designed to represent the performance of some of the largest companies across components of the 20 EURO STOXX Supersector Indexes. The EURO STOXX Supersector Indexes are subsets of the EURO STOXX Index.